Follow
Benjamin G. Barwick, Ph.D.
Title
Cited by
Cited by
Year
Age-associated DNA methylation in pediatric populations
RS Alisch, BG Barwick, P Chopra, LK Myrick, GA Satten, KN Conneely, ...
Genome research 22 (4), 623-632, 2012
4112012
Wnt signaling in triple negative breast cancer is associated with metastasis
N Dey, BG Barwick, CS Moreno, M Ordanic-Kodani, Z Chen, G Oprea-Ilies, ...
BMC cancer 13, 1-15, 2013
2592013
A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation
CG Duncan, BG Barwick, G Jin, C Rago, P Kapoor-Vazirani, DR Powell, ...
Genome research 22 (12), 2339-2355, 2012
2142012
Global DNA methylation remodeling accompanies CD8 T cell effector function
CD Scharer, BG Barwick, BA Youngblood, R Ahmed, JM Boss
The Journal of Immunology 191 (6), 3419-3429, 2013
1962013
Cell of origin and genetic alterations in the pathogenesis of multiple myeloma
BG Barwick, VA Gupta, PM Vertino, LH Boise
Frontiers in immunology 10, 458658, 2019
1952019
Epigenetic programming underpins B cell dysfunction in human SLE
CD Scharer, EL Blalock, T Mi, BG Barwick, SA Jenks, T Deguchi, ...
Nature immunology 20 (8), 1071-1082, 2019
1552019
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone
TM Schmidt, BG Barwick, N Joseph, LT Heffner, CC Hofmeister, L Bernal, ...
Blood Cancer Journal 9 (12), 94, 2019
1542019
Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation
BG Barwick, CD Scharer, APR Bally, JM Boss
Nature immunology 17 (10), 1216-1225, 2016
1392016
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
BG Barwick, P Neri, NJ Bahlis, AK Nooka, MV Dhodapkar, DL Jaye, ...
Nature communications 10 (1), 1911, 2019
1362019
Plasma cell differentiation is controlled by multiple cell division-coupled epigenetic programs
CD Scharer, BG Barwick, M Guo, APR Bally, JM Boss
Nature communications 9 (1), 1698, 2018
1162018
YAP1 expression in SCLC defines a distinct subtype with T-cell–inflamed phenotype
TK Owonikoko, B Dwivedi, Z Chen, C Zhang, B Barwick, V Ernani, ...
Journal of Thoracic Oncology 16 (3), 464-476, 2021
1142021
EZH2 represses the B cell transcriptional program and regulates antibody-secreting cell metabolism and antibody production
M Guo, MJ Price, DG Patterson, BG Barwick, RR Haines, AK Kania, ...
The Journal of Immunology 200 (3), 1039-1052, 2018
1112018
Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner
N Dey, B Young, M Abramovitz, M Bouzyk, B Barwick, P De, ...
PloS one 8 (10), e77425, 2013
1012013
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
N Prokhnevska, MA Cardenas, RM Valanparambil, E Sobierajska, ...
Immunity 56 (1), 107-124. e5, 2023
1002023
ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in naïve SLE B cells
CD Scharer, EL Blalock, BG Barwick, RR Haines, C Wei, I Sanz, JM Boss
Scientific reports 6 (1), 27030, 2016
992016
B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation
BG Barwick, CD Scharer, RJ Martinez, MJ Price, AN Wein, RR Haines, ...
Nature communications 9 (1), 1900, 2018
972018
Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts
BG Barwick, M Abramovitz, M Kodani, CS Moreno, R Nam, W Tang, ...
British journal of cancer 102 (3), 570-576, 2010
862010
MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myeloma
D Wang, H Hashimoto, X Zhang, BG Barwick, S Lonial, LH Boise, ...
Nucleic acids research 45 (5), 2396-2407, 2017
832017
Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer
B Zhang, Y Li, Q Wu, L Xie, B Barwick, C Fu, X Li, D Wu, S Xia, J Chen, ...
Nature Communications 12 (1), 1714, 2021
762021
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
R Bajpai, A Sharma, A Achreja, CL Edgar, C Wei, AA Siddiqa, VA Gupta, ...
Nature communications 11 (1), 1228, 2020
732020
The system can't perform the operation now. Try again later.
Articles 1–20